Disease · MONDO_0011918
Comparisons in its trials55
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 20 of 55
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Oral Micronized Progesterone vs Placebo Comparator: deaths from any cause | 0 of 93 | 0 of 96 | 189 | NCT01464697 | Trial comparisons |
| Oral Micronized Progesterone vs Placebo Comparator: serious adverse events | 0 of 93 | 0 of 96 | 189 | NCT01464697 | Trial comparisons |
| Oral Micronized Progesterone vs Placebo Comparator: Percentage of Women With Perceived Changes in Menstrual Flow | 65 of 90 | 74 of 86 | 176 | NCT01464697 | Trial comparisons |
| Dexmedetomidine vs Control: deaths from any cause | 0 of 80 | 1 of 81 | 161 | NCT02819141 | Trial comparisons |
| Dexmedetomidine vs Control: serious adverse events | 12 of 80 | 5 of 81 | 161 | NCT02819141 | Trial comparisons |
| Music Group vs Midazolam Group: deaths from any cause | 0 of 77 | 0 of 80 | 157 | NCT03069677 | Trial comparisons |
| Music Group vs Midazolam Group: serious adverse events | 0 of 77 | 0 of 80 | 157 | NCT03069677 | Trial comparisons |
| Low Dose Condition (Group) vs High Dose Condition (Group): serious adverse events | 0 of 56 | 0 of 56 | 112 | NCT00465595 | Trial comparisons |
| Intranasal Oxytocin vs Placebo: deaths from any cause | 0 of 51 | 0 of 54 | 105 | NCT03593473 | Trial comparisons |
| Intranasal Oxytocin vs Placebo: serious adverse events | 0 of 51 | 0 of 54 | 105 | NCT03593473 | Trial comparisons |
| Testosterone vs Placebo: deaths from any cause | 0 of 43 | 0 of 47 | 90 | NCT01121211 | Trial comparisons |
| Testosterone vs Placebo: serious adverse events | 4 of 43 | 1 of 47 | 90 | NCT01121211 | Trial comparisons |
| Citalopram vs Placebo: serious adverse events | 0 of 40 | 0 of 41 | 81 | NCT00962039 | Trial comparisons |
| Dexmedetomidine vs Placebo: Patients With Postoperative Vomiting in Two Groups | 0 of 40 | 1 of 41 | 81 | NCT02108171 | Trial comparisons |
| Dexmedetomidine vs Placebo: Patients With Postoperative Shivering in Two Groups | 1 of 40 | 4 of 41 | 81 | NCT02108171 | Trial comparisons |
| Dexmedetomidine vs Placebo: Patients With Intra-operative Awareness in Two Groups | 0 of 40 | 0 of 41 | 81 | NCT02108171 | Trial comparisons |
| Dexmedetomidine vs Placebo: Patients With Postoperative Nausea in Two Groups | 1 of 40 | 3 of 41 | 81 | NCT02108171 | Trial comparisons |
| Dexmedetomidine vs Placebo: serious adverse events | 0 of 40 | 0 of 41 | 81 | NCT02108171 | Trial comparisons |
| Cannabidiol vs Placebo: deaths from any cause | 0 of 38 | 0 of 38 | 76 | NCT02902081 | Trial comparisons |
| Cannabidiol vs Placebo: serious adverse events | 0 of 38 | 0 of 38 | 76 | NCT02902081 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0011918/comparisons